08:00 , Feb 13, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Choline kinase-a (CHKA) In vitro studies identified a CHKA inhibitor that...
07:00 , Oct 22, 2012 |  BioCentury  |  Emerging Company Profile

Sprint: Quick start in cancer

Sprint Bioscience AB is leveraging its founders' expertise in fragment-based drug discovery and structural biology to generate leads against novel cancer metabolism and autophagy targets. The biotech hopes to out-license its therapeutics when the molecules...
00:51 , Jul 2, 2010 |  BC Extra  |  Financial News

Advanced Cancer Therapeutics raises $10 million

Advanced Cancer Therapeutics LLC (Louisville, Ky.) raised $10 million in seed financing from undisclosed high net-worth individuals and institutions in Kentucky. The company has three lead programs to treat cancer: small molecule inhibitors for 6-phosphofructo-2-kinase...
08:00 , Nov 9, 2009 |  BC Week In Review  |  Clinical News

Advanced Cancer Therapeutics preclinical data

Researchers at the University of Louisville published in Oncogene that selective inhibition of choline kinase (CHK) expression simultaneously attenuated two cellular signaling pathways required for cancer cell growth and survival - the mitogen...
07:00 , Jun 8, 2009 |  BC Week In Review  |  Company News

Advanced Cancer Therapeutics, University of Louisville deal

Advanced Cancer received exclusive, worldwide rights from the university's James Graham Brown Cancer Center to develop and commercialize CK37. The small molecule inhibitor of choline kinase (CHK) is in preclinical testing for cancer....
07:00 , Oct 9, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Neurology ...